This Lung Cancer Awareness Month, Medtronic and A Breath of Hope Lung Foundation are partnering to elevate awareness about lung cancer and empower people with educational tools to help those navigating lung cancer.
Educating yourself about lung cancer is essential for taking an active role in your health. Understanding risk factors, symptoms, screening options, and treatment advances empowers you to make informed decisions and advocate effectively for the best care. Knowledge about lung cancer, including the latest research and personalized treatment options like biomarker testing, can improve outcomes and help you navigate conversations with healthcare providers with confidence. Being well-informed transforms fear into action and ensures that you or your loved ones receive the most appropriate, timely care.
Understand how lung cancer develops and what increases your risk. There are two main types—non-small cell (NSCLC) and small cell (SCLC). NSCLC is the most common in the U.S., and SCLC is the second most common. You’ll learn what may cause these cancers, their risk factors, and why they can affect anyone—even those who have never smoked.
Learn how low-dose CT (LDCT) screening can detect lung cancer early — when it’s most treatable. Understand who qualifies, how the scan works, and why screening is safe.
This animation explains the methods doctors use to diagnose lung cancer, from imaging tests like chest X-rays and CT scans to biopsies and lab tests. Learn how these tools help identify lung cancer and guide treatment decisions.
Understanding comprehensive biomarker testing for non-small cell lung cancer (NSCLC) and why it’s critical for every diagnosis. Biomarker testing identifies specific mutations that drive cancer growth and changes in the PD-L1 protein, helping doctors tailor the most effective treatment for your unique cancer.
Most patients with lung cancer receive more than one type of treatment, which can include surgery, radiation, chemotherapy, or immunotherapy. Supportive treatments are also used to ease pain and discomfort, manage side effects, reduce stress and anxiety, and help with smoking cessation. Palliative care can further improve quality of life by addressing symptoms and comfort needs.
Clinical trials are research studies where people volunteer to help test new treatments, procedures, or ways to detect and manage lung cancer. They are essential for developing safer, more effective treatments and advancing care for future patients. This animation covers how trials are conducted, including study design, eligibility, informed consent, safeguards, trial phases, and potential benefits and risks.
Biomarkers are specific genes, proteins, or other molecules in cancer cells that can influence how non-small cell lung cancer (NSCLC) grows and responds to treatment. Testing for biomarkers helps your doctor choose the most effective therapies, including targeted treatments and immunotherapy.
Treatment for EGFR Mutation
Treatment for KRAS Mutation
Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
Preparing for lung cancer surgery can be challenging, but prehabilitation (“prehab”) can make a big difference. This video explains how prehab strengthens your body and mind before surgery—helping improve lung function, nutrition, and overall recovery. Learn how simple exercises, breathing techniques, and healthy habits can boost your outcomes and quality of life after treatment.
Understand how lung cancer develops and what increases your risk. There are two main types—non-small cell (NSCLC) and small cell (SCLC). NSCLC is the most common in the U.S., and SCLC is the second most common. You’ll learn what may cause these cancers, their risk factors, and why they can affect anyone—even those who have never smoked.
Learn how low-dose CT (LDCT) screening can detect lung cancer early — when it’s most treatable. Understand who qualifies, how the scan works, and why screening is safe.
This animation explains the methods doctors use to diagnose lung cancer, from imaging tests like chest X-rays and CT scans to biopsies and lab tests. Learn how these tools help identify lung cancer and guide treatment decisions.
Understanding comprehensive biomarker testing for non-small cell lung cancer (NSCLC) and why it’s critical for every diagnosis. Biomarker testing identifies specific mutations that drive cancer growth and changes in the PD-L1 protein, helping doctors tailor the most effective treatment for your unique cancer.
Most patients with lung cancer receive more than one type of treatment, which can include surgery, radiation, chemotherapy, or immunotherapy. Supportive treatments are also used to ease pain and discomfort, manage side effects, reduce stress and anxiety, and help with smoking cessation. Palliative care can further improve quality of life by addressing symptoms and comfort needs.
Clinical trials are research studies where people volunteer to help test new treatments, procedures, or ways to detect and manage lung cancer. They are essential for developing safer, more effective treatments and advancing care for future patients. This animation covers how trials are conducted, including study design, eligibility, informed consent, safeguards, trial phases, and potential benefits and risks.
Preparing for lung cancer surgery can be challenging, but prehabilitation (“prehab”) can make a big difference. This video explains how prehab strengthens your body and mind before surgery—helping improve lung function, nutrition, and overall recovery. Learn how simple exercises, breathing techniques, and healthy habits can boost your outcomes and quality of life after treatment.
Biomarkers are specific genes, proteins, or other molecules in cancer cells that can influence how non-small cell lung cancer (NSCLC) grows and responds to treatment. Testing for biomarkers helps your doctor choose the most effective therapies, including targeted treatments and immunotherapy.
